Everbridge, Inc. - EVBG STOCK NEWS

Everbridge has announced the launch of the next generation of its Resident Connection solution, enhancing the reach of emergency alerts for residents and businesses. The updated system aggregates data from over 300 sources, offering access to more than 225 million resident and 28 million business contacts in the U.S. This solution aims to improve communication during crises, specifically for vulnerable populations. The State of Connecticut successfully doubled its emergency reach with this tool, and similar implementations have been seen in other states, showcasing its effectiveness in critical situations.

Everbridge, Inc. (NASDAQ: EVBG) announced that Sarasota County, Florida, expanded its use of the company's Vaccine Distribution solution amid increased vaccine eligibility. Following an executive order, the county implemented Everbridge Smart Orchestration to manage registrations and automate notifications for the newly eligible population. Florida's vaccination efforts are ramping up, with over 400,000 doses distributed weekly. Everbridge aims to streamline the vaccine administration process, contributing to public safety and COVID-19 relief efforts.

Everbridge, a leader in critical event management, has been selected by a major intergovernmental organization to implement its Vaccine Distribution software across multiple countries. This decision follows a thorough evaluation, emphasizing Everbridge's capability to automate vaccine scheduling, tracking, and communication for millions of doses. The deployment aims to enhance the organization’s humanitarian efforts amid the ongoing COVID-19 pandemic, solidifying Everbridge's role in global vaccine logistics.

Everbridge has successfully completed its offering of $375 million in convertible senior notes due 2026, with net proceeds estimated at approximately $364 million after fees. Notably, $35 million was allocated for capped call transactions, while about $59 million was used to repurchase existing convertible notes due 2022, totaling $58.6 million. Importantly, these notes and any shares from conversions are not registered under the Securities Act, restricting their sale without appropriate exemptions.

Everbridge (NASDAQ: EVBG) has been selected by the Muscogee (Creek) Nation Health System to implement its Vaccine Distribution solution, aimed at streamlining the administration of COVID-19 vaccines for over 90,000 tribal members. This deployment marks a significant enhancement in vaccination coordination, automating processes like registration, scheduling, and reporting. The Muscogee Nation is among several Native American tribes benefiting from Everbridge's offerings, demonstrating the company's commitment to supporting health initiatives during the pandemic.

Everbridge (NASDAQ: EVBG) announced its participation in the SXSW Conference, where Dr. John Maeda will present his findings in a session titled “2021 CX Report: Safety Eats the World” on March 16, 2021. The talk will focus on the significance of Critical Event Management (CEM) technology in enhancing human safety and business resilience amidst rising global crises. Attendees can expect key insights on using technology for risk management, COVID-19 lessons, and the importance of embracing risks for business growth.

Everbridge, Inc. (Nasdaq: EVBG) has priced $325 million of 0% convertible senior notes due 2026. The offering includes an option to purchase an additional $50 million in notes. The notes will be issued at par, with a conversion rate of 5.5341 shares per $1,000, representing a 40% premium over the recent stock price. Everbridge expects to net approximately $315.7 million, primarily to repurchase its existing 2022 convertible notes and for general corporate purposes. The transaction is expected to close on March 11, 2021.

Everbridge (Nasdaq: EVBG) plans to offer $275 million in convertible senior notes due 2026 in a private placement to qualified institutional buyers. An additional $50 million option may be granted to initial purchasers. Proceeds will be used to buy back existing 1.50% convertible senior notes due 2022 and for general corporate purposes, including marketing and potential acquisitions. The notes will be unsecured and convertible into cash, common stock, or a combination thereof. Market conditions will influence the offering's terms and pricing.